SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 35 filers reported holding SPRING BK PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $535,000 | +0.9% | 51,015 | 0.0% | 0.05% | -18.3% |
| Q4 2018 | $530,000 | -46.9% | 51,015 | -31.3% | 0.06% | -48.7% |
| Q4 2017 | $999,000 | -62.8% | 74,309 | -53.4% | 0.12% | -69.5% |
| Q3 2017 | $2,685,000 | +13.3% | 159,417 | -8.9% | 0.38% | -5.0% |
| Q2 2017 | $2,370,000 | – | 175,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 953,301 | $11,487,000 | 1.01% |
| Morse Asset Management, Inc | 190,050 | $2,290,000 | 0.60% |
| Stonepine Capital Management, LLC | 71,050 | $856,000 | 0.50% |
| SECTORAL ASSET MANAGEMENT INC | 291,656 | $3,514,000 | 0.37% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 277,363 | $3,342,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 73,000 | $673,000 | 0.32% |
| TIEDEMANN ADVISORS, LLC | 412,049 | $4,964,000 | 0.29% |
| CAXTON CORP | 20,986 | $253,000 | 0.23% |
| Sofinnova Investments, Inc. | 189,646 | $2,285,000 | 0.20% |
| Private Capital Advisors, Inc. | 52,335 | $631,000 | 0.17% |